CIK 1465837
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2024-Q2. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 75.14% | 51 |
| Unclassified | 24.80% | 16 |
| Health Care Equipment & Supplies | 0.06% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | RVMD | Revolution Medicines, Inc. | Health Care | 9.52% |
| 2 | TYRA | Tyra Biosciences, Inc. | Health Care | 7.44% |
| 3 | NUVL | Nuvalent, Inc. | Health Care | 5.62% |
| 4 | ONC | BeOne Medicines Ltd. | Health Care | 5.51% |
| 5 | CYTK | CYTOKINETICS INC | Health Care | 5.44% |
| 6 | SPRINGWORKS THERAPEUTICS INC COM | Unclassified | 5.38% | |
| 7 | MERUS N V | Unclassified | 4.66% | |
| 8 | SRPT | Sarepta Therapeutics, Inc. | Health Care | 3.98% |
| 9 | AVIDITY BIOSCIENCES INC | Unclassified | 3.89% | |
| 10 | IDYA | IDEAYA Biosciences, Inc. | Health Care | 3.42% |
52/68 names classified · sector 75.2% of weight · industry 75.2% · mkt cap 71.1%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 75.2% of the book is sector-classified (unclassified names shown, never dropped).
Only 6% of book weight classified — the grid is NOT representative of the whole book.
Classified: 5.5% of book weight (1/55 names) · unclassified 94.5%: , RVMD, TYRA, NUVL, CYTK, SRPT, IDYA, TNGX, ARGX, ANAB +44 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | RVMDREVOLUTION MEDICINES INC | 4,279,464 | $194M | 9.5% | HOLD |
| 2 | TYRATYRA BIOSCIENCES INC | 6,448,359 | $152M | 7.4% | HOLD |
| 3 | NUVLNUVALENT INC | 1,120,192 | $115M | 5.6% | HOLD |
| 4 | ONCBEONE MEDICINES LTD | 500,000 | $112M | 5.5% | HOLD |
| 5 | CYTKCYTOKINETICS INC | 2,100,000 | $111M | 5.4% | HOLD |
| 6 | SPRINGWORKS THERAPEUTICS INC COM | 3,421,541 | $110M | 5.4% | HOLD |
| 7 | MERUS N V | 1,900,000 | $95M | 4.7% | HOLD |
| 8 | SRPTSAREPTA THERAPEUTICS INC | 650,000 | $81M | 4.0% | HOLD |
| 9 | AVIDITY BIOSCIENCES INC | 1,727,388 | $79M | 3.9% | HOLD |
| 10 | IDYAIDEAYA BIOSCIENCES INC | 2,202,812 | $70M | 3.4% | HOLD |
| 11 | TNGXTANGO THERAPEUTICS INC | 8,198,642 | $63M | 3.1% | HOLD |
| 12 | ARGXARGENX SE | 100,000 | $54M | 2.7% | HOLD |
| 13 | APELLIS PHARMACEUTICALS INC | 1,726,000 | $50M | 2.4% | HOLD |
| 14 | AKERO THERAPEUTICS INC | 1,676,733 | $48M | 2.4% | HOLD |
| 15 | ANABANAPTYSBIO INC | 1,300,000 | $44M | 2.1% | HOLD |
| 16 | AXSMAXSOME THERAPEUTICS INC. | 400,000 | $36M | 1.8% | HOLD |
| 17 | ITEOS THERAPEUTICS INC COM | 2,946,915 | $30M | 1.5% | HOLD |
| 18 | LEGNLEGEND BIOTECH CORP | 600,000 | $29M | 1.4% | HOLD |
| 19 | GERNGERON CORP | 6,000,000 | $27M | 1.3% | HOLD |
| 20 | THIRD HARMONIC BIO INC COM | 2,000,000 | $27M | 1.3% | HOLD |
| 21 | RCKTROCKET PHARMACEUTICALS INC | 1,466,051 | $27M | 1.3% | HOLD |
| 22 | RCUSARCUS BIOSCIENCES INC | 1,602,200 | $24M | 1.2% | HOLD |
| 23 | TILINSTIL BIO INC | 355,500 | $24M | 1.2% | NEW |
| 24 | XENEXENON PHARMACEUTICALS INC | 600,000 | $24M | 1.2% | HOLD |
| 25 | IMVTIMMUNOVANT INC | 825,000 | $24M | 1.2% | HOLD |
| 26 | KYMRKYMERA THERAPEUTICS INC | 450,000 | $21M | 1.0% | NEW |
| 27 | SYRESPYRE THERAPEUTICS INC | 696,480 | $20M | 1.0% | HOLD |
| 28 | KURAKURA ONCOLOGY INC | 1,000,000 | $20M | 1.0% | HOLD |
| 29 | KALVISTA PHARMACEUTICALS INC | 1,590,000 | $18M | 0.9% | HOLD |
| 30 | NKTXNKARTA INC | 4,029,606 | $18M | 0.9% | TRIM −28% |
| 31 | ORICORIC PHARMACEUTICALS INC | 1,732,571 | $18M | 0.9% | HOLD |
| 32 | GPCRSTRUCTURE THERAPEUTICS INC | 400,000 | $18M | 0.9% | HOLD |
| 33 | FATEFATE THERAPEUTICS INC | 4,960,910 | $17M | 0.9% | TRIM −40% |
| 34 | ELVNENLIVEN THERAPEUTICS INC | 671,358 | $17M | 0.8% | HOLD |
| 35 | REPLREPLIMUNE GROUP INC | 1,536,341 | $17M | 0.8% | HOLD |
| 36 | DAY ONE BIOPHARMACEUTICALS I | 1,189,943 | $17M | 0.8% | HOLD |
| 37 | CGEMCULLINAN THERAPEUTICS INC | 907,895 | $15M | 0.7% | ADD 38% |
| 38 | ARVNARVINAS INC | 608,614 | $15M | 0.7% | HOLD |
| 39 | CLYMCLIMB BIO INC | 2,603,190 | $13M | 0.7% | HOLD |
| 40 | RLAYRELAY THERAPEUTICS INC | 1,819,132 | $13M | 0.6% | HOLD |
| 41 | NRIXNURIX THERAPEUTICS INC | 563,067 | $13M | 0.6% | NEW |
| 42 | PRTAPROTHENA CORP PLC | 690,000 | $12M | 0.6% | HOLD |
| 43 | QUREUNIQURE NV | 2,225,000 | $11M | 0.5% | NEW |
| 44 | APGEAPOGEE THERAPEUTICS INC | 179,000 | $11M | 0.5% | NEW |
| 45 | OLMAOLEMA PHARMACEUTICALS INC | 650,000 | $8M | 0.4% | HOLD |
| 46 | IOVAIOVANCE BIOTHERAPEUTICS INC | 750,000 | $7M | 0.3% | HOLD |
| 47 | IPSCCENTURY THERAPEUTICS INC | 3,900,000 | $7M | 0.3% | TRIM −20% |
| 48 | JSPRJASPER THERAPEUTICS INC | 350,000 | $7M | 0.3% | HOLD |
| 49 | SANASANA BIOTECHNOLOGY INC | 1,545,000 | $6M | 0.3% | HOLD |
| 50 | TERNS PHARMACEUTICALS INC | 752,000 | $6M | 0.3% | NEW |
| 51 | SRRKSCHOLAR ROCK HLDG CORP | 750,000 | $6M | 0.3% | NEW |
| 52 | POSEIDA THERAPEUTICS INC | 2,000,000 | $6M | 0.3% | TRIM −55% |
| 53 | SMMTSUMMIT THERAPEUTICS INC | 250,000 | $5M | 0.3% | NEW |
| 54 | ENGENE HOLDINGS INC | 727,900 | $5M | 0.2% | HOLD |
| 55 | PRLDPRELUDE THERAPEUTICS INC | 1,708,187 | $4M | 0.2% | TRIM −33% |
| 56 | BCAXBICARA THERAPEUTICS INC | 135,000 | $3M | 0.2% | NEW |
| 57 | MERSANA THERAPEUTICS INC COM | 1,817,000 | $3M | 0.2% | NEW |
| 58 | BOLDBOUNDLESS BIO INC | 711,329 | $2M | 0.1% | HOLD |
| 59 | BDTXBLACK DIAMOND THERAPEUTICS I | 506,000 | $2M | 0.1% | HOLD |
| 60 | ZNTLZENTALIS PHARMACEUTICALS INC | 450,000 | $2M | 0.1% | HOLD |
| 61 | TARAPROTARA THERAPEUTICS INC | 811,627 | $1M | 0.1% | HOLD |
| 62 | OBIOORCHESTRA BIOMED HLDGS INC | 238,193 | $1M | 0.1% | HOLD |
| 63 | ZURAZURA BIO LTD | 300,000 | $1M | 0.1% | NEW |
| 64 | BCABBIOATLA INC | 686,347 | $1M | 0.1% | HOLD |
| 65 | MISTMILESTONE PHARMACEUTICALS IN | 309,007 | $469,691 | 0.0% | HOLD |
| 66 | DBV TECHNOLOGIES S A | 250,000 | $175,000 | 0.0% | NEW |
| 67 | NUVBNUVATION BIO INC | 266,666 | $26,107 | 0.0% | HOLD |
| 68 | SRZNWSURROZEN INC | 66,666 | $1,333 | 0.0% | HOLD |
Where this firm's principals came from and which firms its alumni went on to found.
